Hasil Pencarian - Yu‐Fa Li
- Menampilkan 1 - 6 hasil dari 6
-
1
-
2
Dynamic 18F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer oleh Zhi‐Yong Chen, Rui Fu, Xiao‐Yue Tan, Li‐Xu Yan, Wen‐Fang Tang, Zhen‐Bin Qiu, Yi‐Fan Qi, Yu‐Fa Li, Qing‐Yi Hou, Yi‐Long Wu, Wen‐Zhao Zhong, Ben‐Yuan Jiang
Diterbitkan 2022-09-01
Artikel -
3
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer oleh Zhong-Yi Dong, Jia-Tao Zhang, Si-Yang Liu, Jian Su, Chao Zhang, Zhi Xie, Qing Zhou, Hai-Yan Tu, Chong-Rui Xu, Li-Xu Yan, Yu-Fa Li, Wen-Zhao Zhong, Yi-Long Wu
Diterbitkan 2017-11-01
Artikel -
4
Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement oleh Qing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, Yu-Qing Chen, Yu-Fa Li, Chang Lu, Jun-Wei Su, Quan-Quan Tan, Chan-Yuan Zhang, Jiao Yang, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Yang
Diterbitkan 2023-01-01
Artikel -
5
The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients oleh Yu-Qing Chen, Ling-Ling Gao, Ling-Cong Kong, Xu-Hui Guan, Huan Yang, Yu-Fa Li, Zhi-Yi Lv, Xu-Chao Zhang, Hui-Ying Liang, Hua-Jun Chen, Yi-Long Wu, Jie Huang, Jin-Ji Yang
Diterbitkan 2023-01-01
Artikel -
6
Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report oleh Yu-Qing Chen, BD, Yu-Fa Li, MD, Chan-Yuan Zhang, MD, Shi-Ling Zhang, BD, Zhi-Yi Lv, PhD, Song Dong, PhD, Hua-Jun Chen, PhD, Xu-Chao Zhang, PhD, Yi-Long Wu, MD, Jin-Ji Yang, MD
Diterbitkan 2021-12-01
Artikel